Transaction · 0001610717-26-000164

Saxonov Serge

Saxonov Serge, CEO, reported an open-market or private sale at 10x Genomics, Inc. involving 18175.000000 shares for an estimated $444224.26. Reported holdings after the transaction were 1149098.000000 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SCEO
TXG10x Genomics, Inc.
Trade date
May 22, 2026
Filing date
May 27, 2026
View on SEC Insider profile
Estimated value-$444kShares × reported price
Shares traded18.1k$24.44 per share
Holdings after1.14MDirect
% of reported position traded1.56%This security and ownership context
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 1,167,273 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

TXG price since this filing

Daily closing prices, with the filing date and available return windows
TXG · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago -10.5%1w ago -16.9%1d ago -3.3%
Returns since7d +26.0%30d +44.1%90d +160.1%180d1y

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001610717-26-000164
Class A Common Stock
Transaction date
May 22, 2026
Filed May 27, 2026, 09:57 PM · 5d delay
Shares
18,175 sh
$24.44 per share
Estimated value
-$444k
Computed from shares × price
Holdings after
1,149,098 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Cluster Selling Direct Ownership 10b5-1 Detected
Filing-only score

-4 points

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

How this score is calculated
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
  • tenb5_1_detected-10 points

    is_10b5_1 = true

    Stored filing content includes detected 10b5-1 language.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Chief Executive Officer

Officer YesDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.

  2. F2

    The transaction reported herein was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on November 29, 2025.

  3. F3

    This transaction was executed in multiple trades at prices ranging from $24.45 to $24.88, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person undertakes…

  4. F4

    The shares are held by the Andromeda Trust, for which the Reporting Person serves as trustee.

  5. F5

    The shares are held by the Y/S Descendants' Trust, for which the Reporting Person serves as trustee.

  6. F6

    The shares are held by the Y/S Pot Trust, for which the Reporting Person serves as trustee.

Original filing · 0001610717-26-000164
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

TXG